References
- Prosser J., Condie A. Biallelic Apal polymorphism of the human p53 gene (TP53). Nucleic Acids Research 1991; 19: 4799
- Fenaux P., Preudhomme C., Quiquandon I., Jonveaux P., Lai J. L., Vanrumbeke M., Loucheux-Lefebvre M. H., Bauters F., Berger R., Kerckaert J. P. Mutations of the P53 gene in acute myeloid leukemia. British Journal of Haematology 1992; 80: 178–183
- Peller S., Kopilova Y., Slutzki S., Halevy A., Kvitko K., Rotter V. A novel polymorphism in intron 6 of the human p53 gene: a possible association with cancer predisposition and susceptibility. DNA and Cell Biology 1995; 14: 983–990
- Avigad S., Barel D., Blau O., Malka A., Zoldan M., Mor C., Fogel M., Cohen I. J., Stark B., Goshen Y., Stein J., Zaizov R. A novel p53 mutation in intron 6 in diverse childhood malignancies. Oncogene 1997; 14: 1541–1545
- Hillebrandt S., Streffer C., Demidchik E. P., Biko J., Reiners C. Polymorphisms in the p53 gene in thyroid tumors and blood samples of children from areas in Belarus. Mutation Research 1997; 381: 201–207
- Willems P. M. W., Meyerink J. P. P., van de Locht L. T. F., Smetsers T. E.C. M., de Vries N., Mensink E. J.B. M. PCR detection of a BgIII polymorphism in intron 1 of the human p53 gene (TP53). Nucleic Acids Research 1992; 20(5)1172
- Futreal P. A., Barrett J. C., Wiseman R. W. An Alu polymorphism intragenic to the TP53 gene. Nucleic Acids Research 1991; 19(24)6977
- Pleasants L. M., Hansen M. F. Identification of a polymorphism in intron 2 of the p53 gene. Human Genetics 1994; 93: 607–608
- Lazar V., Hazard F., Bertin F., Janin N., Bellet D., Bressac B. Simple sequence repeat polymorphism within the p53 gene. Oncogene 1993; 8: 1703–1705
- Shamsher M., Montano X. Analysis of intron 4 of the p53 gene in human cutaneous melanoma. Gene 1996; 176: 259–262
- Buller R. E., Skilling J. S., Kaliszewski S., Niemann T., Anderson B. Absence of significant germ line p53 mutations in ovarian cancer patients. Gynecologic Oncology 1995; 58: 368–374
- Wang-Gohrke S., Weikel W., Riscn H., Vesprini D., Abrahamson J., Lerman C., Godwin A., Moslehi R., Olipade O., Brunet J. -S., Stickeler E., Kiback D. G., Kreienberg R., Weber B., Narod S. A., Runnebaum I. B. Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. British Journal of Cancer 1999; 81(1)179–183